Ewing tumor after treatment of Ki-1+ anaplastic large cell lymphoma. Therapy-associated secondary neoplasm or unrelated coincidence?

[1]  H. Kovar,et al.  Variability of EWS chimaeric transcripts in Ewing tumours: a comparison of clinical and molecular data. , 1994, British Journal of Cancer.

[2]  T. Triche,et al.  The Ewing family of tumors--a subgroup of small-round-cell tumors defined by specific chimeric transcripts. , 1994, The New England journal of medicine.

[3]  M. Tiemann,et al.  Successful treatment strategy for Ki-1 anaplastic large-cell lymphoma of childhood: a prospective analysis of 62 patients enrolled in three consecutive Berlin-Frankfurt-Munster group studies. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  D N Shapiro,et al.  Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma. , 1994, Science.

[5]  P. Sorensen,et al.  A second Ewing's sarcoma translocation, t(21;22), fuses the EWS gene to another ETS–family transcription factor, ERG , 1994, Nature Genetics.

[6]  T. Triche,et al.  Combinatorial generation of variable fusion proteins in the Ewing family of tumours. , 1993, The EMBO journal.

[7]  J. Downing,et al.  Fusion of PAX3 to a member of the forkhead family of transcription factors in human alveolar rhabdomyosarcoma. , 1993, Cancer research.

[8]  O. Haas,et al.  Characterization of CD7+CD19+ lymphoid cells after Epstein-Barr virus transformation. , 1993, Journal of immunology.

[9]  R. Simon,et al.  Children and cancer. A perspective from the cancer therapy evaluation program, national cancer institute , 1993, Cancer.

[10]  C. Pratt,et al.  Bone tumors other than osteosarcoma after retinoblastoma , 1993, Cancer.

[11]  G. Thomas,et al.  Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours , 1992, Nature.

[12]  S. Friend,et al.  Germline mutations of the p53 tumor-suppressor gene in children and young adults with second malignant neoplasms. , 1992, The New England journal of medicine.

[13]  J. Gogusev,et al.  Malignant histiocytosis in childhood: a distinctive CD30-positive clinicopathological entity associated with a chromosomal translocation involving 5q35. , 1992, Seminars in diagnostic pathology.

[14]  H Kovar,et al.  MIC2 is a specific marker for ewing's sarcoma and peripheral primitive neuroectodermal tumors. Evidence for a common histogenesis of ewing's sarcoma and peripheral primitive neuroectodermal tumors from MIC2 expression and specific chromosome aberration , 1991, Cancer.

[15]  M. Kadin.  Ki-1-positive anaplastic large-cell lymphoma: a clinicopathologic entity? , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  H. Kovar,et al.  Overexpression of the pseudoautosomal gene MIC2 in Ewing's sarcoma and peripheral primitive neuroectodermal tumor. , 1990, Oncogene.

[17]  R. Larson,et al.  Morphology in Ki‐1 (CD30)‐Positive Non Hodgkin's Lymphoma Is Correlated with Clinical Features and the Presence of a Unique Chromosomal Abnormality, t(2;5)(p23;q35) , 1990, The American journal of surgical pathology.

[18]  R. Larson,et al.  The t(2;5)(p23;q35): a recurring chromosomal abnormality in Ki-1-positive anaplastic large cell lymphoma. , 1989, Leukemia.

[19]  D M Green,et al.  Bone sarcomas linked to radiotherapy and chemotherapy in children. , 1987, The New England journal of medicine.

[20]  P. Chomczyński,et al.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.

[21]  V. Diehl,et al.  Identification of Hodgkin and sternberg‐reed cells as a unique cell type derived from a newly‐detected small‐cell population , 1982, International journal of cancer.

[22]  A. Feller,et al.  Malignant histiocytosis and large cell anaplastic (Ki-1) lymphoma in childhood: guidelines for differential diagnosis--report of the Histiocyte Society. , 1994, Medical and pediatric oncology.

[23]  G. Vawter,et al.  Bone sarcomas as second malignant neoplasms following childhood cancer , 1991, Cancer.

[24]  W. Winkelmann,et al.  Multidisciplinary treatment of primary Ewing's sarcoma of bone. A 6‐year experience of a European cooperative trial , 1988, Cancer.